AllianceBernstein’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Buy |
127,820
+8,600
| +7% | +$31K | ﹤0.01% | 2690 |
|
|
2025
Q1 | $356K | Hold |
119,220
| – | – | ﹤0.01% | 2693 |
|
|
2024
Q4 | $399K | Hold |
119,220
| – | – | ﹤0.01% | 2737 |
|
|
2024
Q3 | $399K | Hold |
119,220
| – | – | ﹤0.01% | 2774 |
|
|
2024
Q2 | $395K | Buy |
119,220
+2,800
| +2% | +$9.27K | ﹤0.01% | 2797 |
|
|
2024
Q1 | $470K | Sell |
116,420
-4,310
| -4% | -$17.4K | ﹤0.01% | 2605 |
|
|
2023
Q4 | $368K | Sell |
120,730
-3,890
| -3% | -$11.9K | ﹤0.01% | 2756 |
|
|
2023
Q3 | $374K | Hold |
124,620
| – | – | ﹤0.01% | 2713 |
|
|
2023
Q2 | $466K | Buy |
124,620
+35,120
| +39% | +$131K | ﹤0.01% | 2673 |
|
|
2023
Q1 | $300K | Buy |
89,500
+4,200
| +5% | +$14.1K | ﹤0.01% | 2773 |
|
|
2022
Q4 | $410K | Buy |
85,300
+5,200
| +6% | +$25K | ﹤0.01% | 2739 |
|
|
2022
Q3 | $456K | Hold |
80,100
| – | – | ﹤0.01% | 2688 |
|
|
2022
Q2 | $569K | Hold |
80,100
| – | – | ﹤0.01% | 2618 |
|
|
2022
Q1 | $578K | Buy |
80,100
+200
| +0.3% | +$1.44K | ﹤0.01% | 2603 |
|
|
2021
Q4 | $714K | Sell |
79,900
-16,388
| -17% | -$146K | ﹤0.01% | 2584 |
|
|
2021
Q3 | $3.38M | Buy |
96,288
+6,488
| +7% | +$227K | ﹤0.01% | 1825 |
|
|
2021
Q2 | $1.93M | Buy |
89,800
+70,998
| +378% | +$1.53M | ﹤0.01% | 2205 |
|
|
2021
Q1 | $1.16M | Buy |
18,802
+6,102
| +48% | +$377K | ﹤0.01% | 2334 |
|
|
2020
Q4 | $531K | Buy |
+12,700
| New | +$531K | ﹤0.01% | 2550 |
|